Global Computational Biology Market -Global Trends and Forecasts(2025 to 2034)
Description
Computational Biology Market Size And Forecast
According to Factview Research, Global Computational Biology Market was valued at USD 3.33 Billion in 2024 and is projected to reach USD 19.63 Billion by 2034, growing at a CAGR of 21.7% from 2025 to 2034.
Global Computational Biology Market Outlook
The increasing penetration for research studies owing to the development and discovery of drugs is the major factor propelling the market growth. In addition, the enhancement in the disease modeling, drug designing, and growing demand for the predictive models led to imposing positive factors on market growth. Furthermore, increasing government initiative providing funding for R&D activities propel the growth of the market. However, the unavailability of the operator to operate the computational tools, expected to hamper the market growth.
Global Computational Biology Market Competitive Landscape
The Global Computational Biology Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Accelrys, Chemical Computing Group Inc., Entelos, In-silico Biotechnology AG , Nimbus Discovery LLC, Rhenovia Pharma SAS Certara, Compugen Ltd, Generate AG, Leadscope Inc., and Rhenovia Pharma SAS.
According to Factview Research, Global Computational Biology Market was valued at USD 3.33 Billion in 2024 and is projected to reach USD 19.63 Billion by 2034, growing at a CAGR of 21.7% from 2025 to 2034.
Global Computational Biology Market Outlook
The increasing penetration for research studies owing to the development and discovery of drugs is the major factor propelling the market growth. In addition, the enhancement in the disease modeling, drug designing, and growing demand for the predictive models led to imposing positive factors on market growth. Furthermore, increasing government initiative providing funding for R&D activities propel the growth of the market. However, the unavailability of the operator to operate the computational tools, expected to hamper the market growth.
Global Computational Biology Market Competitive Landscape
The Global Computational Biology Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Accelrys, Chemical Computing Group Inc., Entelos, In-silico Biotechnology AG , Nimbus Discovery LLC, Rhenovia Pharma SAS Certara, Compugen Ltd, Generate AG, Leadscope Inc., and Rhenovia Pharma SAS.
Table of Contents
102 Pages
- 1 Introduction Of Global Computational Biology Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Computational Biology Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Computational Biology Market, By Application
- 5.1 Overview
- 5.2 Preclinical Drug Development
- 5.3 Human Body Simulation Software
- 5.4 Drug Discovery &Amp; Disease Modelling
- 5.5 Cellular &Amp; Biological Simulation
- 5.6 Others
- 6 Global Computational Biology Market, By End-user
- 6.1 Overview
- 6.2 Industry
- 6.3 Commercial
- 6.4 Academics
- 7 Global Computational Biology Market, By Geography
- 7.1 Overview
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest Of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest Of Asia Pacific
- 7.5 Rest Of The World
- 7.5.1 Latin America
- 7.5.2 Middle East
- 8 Global Computational Biology Market Competitive Landscape
- 8.1 Overview
- 8.2 Company Market Ranking
- 8.3 Key Development Strategies
- 9 Company Profiles
- 9.1 Accelrys
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 Chemical Computing Group Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 Entelos
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 In-silico Biotechnology Ag
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 Nimbus Discovery Llc
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Rhenovia Pharma Sas
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Certara
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 9.8 Compugen Ltd
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
- 9.9 Generate Ag
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
- 9.10 Leadscope Inc
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
- 10 Appendix
- 10.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



